Live feed08:00:00·578dPRReleasevia QuantisnowKiromic BioPharma Reports Favorable 10-Month Follow-Up Results for the First Patient Treated in its Deltacel-01 Clinical TrialByQuantisnow·Wall Street's wire, on your screen.KRBP· Kiromic BioPharma Inc.Health Care
